Research Centre for Pharmaceutical Care and Pharmaco-economics, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Onderwijs en Navorsing 2, PO Box 521, Herestraat 49, 3000 Leuven, Belgium.
Expert Rev Clin Pharmacol. 2008 Jul;1(4):497-503. doi: 10.1586/17512433.1.4.497.
Pressure to control pharmaceutical expenditure and price competition among pharmaceutical companies are fuelling the development of generic medicines markets in ambulatory care in Europe. The aim of this special report is to identify, interpret and discuss the main supply and demand trends affecting the European generic medicines market in ambulatory care. On the supply side, generic price-regulated systems and reference pricing systems are spreading across Europe. On the demand side, European countries have attempted to stimulate demand for generic medicines by focusing on physician prescribing, generic substitution by pharmacists and patient copayments. Finally, the development of biosimilars will probably become an important area of growth for the pharmaceutical industry over the next 5 years.
在控制医药支出的压力和制药公司之间的价格竞争推动下,欧洲的门诊护理中的仿制药市场正在发展。本特别报告的目的是确定、解释和讨论影响欧洲门诊护理中仿制药市场的主要供求趋势。在供应方面,仿制药价格调控体系和参考定价体系正在欧洲各地普及。在需求方面,欧洲各国试图通过关注医生的处方、药剂师的仿制药替代和患者共付额来刺激对仿制药的需求。最后,生物类似药的发展在未来 5 年内可能成为制药行业的一个重要增长领域。